参考文献/References:
[1] Ergün EL, Ceylan E. Soft tissue uptake observed on Tc-99m MDP bone scans:rare imaging patterns in two cases[J]. Clin Nucl Med, 2001, 26(11):958-959. DOI:10.1097/00003072-200111000-00023.
[2] Ergün EL, Kiratli PO, Günay EC, et al. A report on the incidence of intestinal 99Tcm-methylene diphosphonate uptake of bone scans and a review of the literature[J]. Nucl Med Commun, 2006, 27(11):877-885. DOI:10.1097/01.mnm.0000237991.44948.13.
[3] Macdonald J. Idiopathic hepatic uptake of 99Tcm methylene diphosphonate:a case report[J]. J Nucl Med Technol, 2001, 29(1):32-36.
[4] Tarsarya S, Marwah A, Shah H, et al. Non-osseous uptake on Tc99m methylene diphosphonate in multiple muscles confirmed on SPECT/computed tomography[J]. Indian J Nucl Med, 2012, 27(3):205-207. DOI:10.4103/0972-3919.112746.
[5] Soundararajan R, Naswa N, Sharma P, et al. SPECT-CT for characterization of extraosseous uptake of 99Tcm-methylene diphosphonate on bone scintigraphy[J]. Diagn Interv Radiol, 2013, 19(5):405-410. DOI:10.5152/dir.2013.054.
[6] Wale DJ, Wong KK, Savas H, et al. Extraosseous findings on bone scintigraphy using fusion SPECT/CT and correlative imaging[J].AJR Am J Roentgenol, 2015, 205(1):160-172. DOI:10.2214/AJR.14.13914.
[7] Tuncel M, Akdemir E. 99Tcm-MDP uptake in thyroid nodule:contribution of SPECT-CT and ultrasonography[J]. Rev Esp Med Nucl Imagen Mol, 2012, 31(1):49-50. DOI:10.1016/j.remn.2011. 05.012.
[8] Kida T, Hujita Y, Sasaki M, et al. Myocardial and vascular uptake of a bone tracer associated with secondary hyperparathyroidism[J]. Eur J Nucl Med, 1986, 12(3):151-154.
[9] Loutfi I, Collier BD, Mohammed AM. Nonosseous abnormalities on bone scans[J]. J Nucl Med Technol, 2003, 31(3):149-153.
[10] Shi X, Jing H, Zhuang H, et al. Diffuse hepatic and splenic uptake of Tc-99m methylene diphosphonate on bone scintigraphy after intravenous administration of gadolinium-containing MRI contrast[J]. Clin Nucl Med, 2011, 36(3):178-182. DOI:10.1097/RLU.0b013e318208f103.
[11] McDevitt GR Jr, Heironimus JD, Toney MO, et al. Diffuse abdominal uptake of technetium-99m-methylene diphosphonate in a patient on continuous ambulatory dialysis during bone scintigraphy[J]. J Nucl Med, 1992, 33(11):2052-2054.
[12] Sherkow L, Ryo UY, Fabich D, et al. Visualization of the liver, gallbladder, and intestine on bone scintigraphy[J]. Clin Nucl Med, 1984, 9(8):440-443.
[13] Al-Enizi E, Kazem N, Owunwanne A, et al. Dextrose solutions yield radiochemical impurities:the "sweet" scans[J]. J Nucl Med Technol, 2003, 31(1):33-36.
[14] Park CH, Kim HS, Shin HY, et al. Hepatic uptake of Tc-99m MDP on bone scintigraphy from intravenous Iron therapy(Blutal)[J]. Clin Nucl Med, 1997, 22(11):762-764.
[15] Flynn BM, Treves ST. Diffuse hepatic uptake of technetium-99m methylene diphosphonate in a patient receiving high dose methotrexate[J]. J Nucl Med, 1987, 28(4):532-534.
[16] Kannivelu A, Padhy AK, Srinivasan S, et al. Extraosseous uptake of technetium-99m methylene diphosphonate by an acute territorial cerebral infarct in a classical biodistribution pattern[J]. Indian J Nucl Med, 2013, 28(4):240-242. DOI:10.4103/0972-3919. 121974.
[17] Sood A, Seam RK, Sethi S, et al. Diffuse hepatic and splenic Tc-99m MDP tracer uptake in case of multiple myeloma[J]. Indian J Nucl Med, 2010, 25(2):70-72. DOI:10.4103/0972-3919.72692.
[18] Bertagna F, Bosio G, Giubbini R. Incidental thyroid Tc-99m methylene diphosphonate(MDP) uptake in a patient affected by polynodular goiter at bone scintigraphy[J]. Nucl Med Rev Cent East Eur, 2009, 12(2):81-82.
[19] Kawase T, Fujii H, Nakahara T, et al. Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer[J]. Clin Nucl Med, 2009, 34(3):173-174. DOI:10.1097/RLU.0b013e31819672b9.
[20] Tondeur M, Michel O, Ham HR. Extraosseous Tc-99m methylene diphosphonate uptake related to pulmonary bleeding[J]. Clin Nucl Med, 1997, 22(4):255-256.
[21] Yang G, Wang X, Wang Z, et al. Tc-99m MDP uptake in a giant pulmonary chondroma[J]. Clin Nucl Med, 2011, 36(11):1029-1030. DOI:10.1097/RLU.0b013e318219b3ad.
[22] Shih WJ, Coupal JJ, Domstad PA, et al. Diffuse thoracoabdominal radioactivity seen in bone imaging[J]. Clin Nucl Med, 1986, 11(4):254-258.
[23] 许华, 陈绍亮, 叶万忠, 等. 骨显像时骨外组织显影的意义[J]. 中华核医学杂志, 2002, 22(1):57. DOI:10.3760/cma.j.issn.2095-2848.2002.01.024. Xu H, Chen SL, Ye WZ, et al. The implications of extraosseous findings on bone scintigraphy[J]. Chin J Nucl Med, 2002, 22(1):57.
[24] Jones DN, Lew W, Wycherley AG. Hepatic uptake of a bone scan agent(99Tcm-MDP) in a patient with amyloidosis associated with plasma cell dyscrasia[J]. Australas Radiol, 1994, 38(1):61-63. DOI:10.1111/j.1440-1673.1994.tb00129.x.
[25] Ali I, Johns W, Gupta SM. Visualization of hepatic metastases of medullary thyroid carcinoma on Tc-99m MDP bone scintigraphy[J].Clin Nucl Med, 2006, 31(10):611-613. DOI:10.1097/01.rlu.0000238256.19694.83.
[26] Mahajan MS, Digamber NS, Sharma R. Technetium-99m-methylene Diphosphonate Uptake in Hepatic Necrosis Secondary to Respiratory Failure[J]. World J Nucl Med, 2013, 12(3):116-119. DOI:10. 4103/1450-1147.136736.
[27] Wang YF, Cherng SC, Chu HC, et al. Hepatic presentation on bone scintigraphy of a patient with acute hepatic failure[J]. Clin Nucl Med, 1999, 24(10):811-812.
[28] Xu YH, Song HJ, Qiu ZL, et al. Multiple extraosseous accumulation of 99Tcm-MDP in acute lymphocytic leukemia and reference to literature[J]. Hell J Nucl Med, 2010, 13(3):273-276.
[29] 景红丽, 陈黎波, 李方, 等. 99Tcm-MDP骨显像发现骨外骨肉瘤腹腔多发转移灶一例[J]. 中华核医学杂志, 2003, 23(2):97. DOI:10.3760/cma.j.issn.2095-2848.2003.02.028. Jing HL, Chen LB, Li F, et al. Visualization of intra-abdominal metastases of osteosarcoma on 99Tcm-MDP bone scintigraphy[J]. Chin J Nucl Med, 2003, 23(2):97.
[30] Martinez-Sanchis B, Cortés-Vizcaíno V, Frontado-Morales L, et al.Intestinal uptake of 99Tcm-MDP:a case report of protein-losing enteropathy correlated with pathology findings from autopsy[J]. Ann Nucl Med, 2011, 25(2):139-141. DOI:10.1007/s12149-010-0445-z.
[31] Gysen M, Verlooy H, Mortelmans L. Extraskeletal uptake of Tc-99m at subcutaneous injection sites in a diabetic patient[J]. Clin Nucl Med, 1998, 23(2):118-119.
[32] Shih WJ, Deland FH, Domstad PA, et al. Unusual persistence of Tc-99m MDP uptake in the incisional scar after thoracotomy[J]. Clin Nucl Med, 1984, 9(10):596-597.
[33] Bhattacharya A, Parmar M, Mittal BR. Extraosseous Tc-99m methylene diphosphonate concentration in the forearm following post-mastectomy lymphatic obstruction[J]. Indian J Nucl Med, 2012, 27(2):105-106. DOI:10.4103/0972-3919.110696.
[34] 付占立, 张旭初, 范岩, 等. 99Tcm-MDP全身骨显像诊断外伤性骨化性肌炎一例[J]. 中华核医学杂志, 2007, 27(4):252. DOI:10.3760/cma.j.issn.2095-2848.2007.04.021. Fu ZL, Zhang XC, Fan Y, et al. The diagnosis of myositis ossificans caused by trauma with 99Tcm-MDP bone scintigraphy:a case report[J]. Chin J Nucl Med, 2007, 27(4):252.
[35] Sainz Esteban A, González Selma ML, Ruiz-Gómez MÁ, et al.Extensive extra-osseous accumulation of 99Tcm-hydroximethylene diphosphonate in a patient with unsuspected dermatomyositis:Whole-body scintigraphy and SPECT/CT[J]. Rev Esp Med Nucl Imagen Mol, 2014, 33(4):255-256. DOI:10.1016/j.remn.2013. 10.004.
[36] Mochizuki T, Tauxe WN, Perper JA. Technetium-99m MDP scintigraphy of rhabdomyolysis induced by exertional heat stroke:a case report[J]. Ann Nucl Med, 1990, 4(3):111-113.
[37] Groell R, Aigner R. Extraosseous uptake of Tc-99m methylene diphosphonate in the pectoralis muscles 8 days after exercise[J].Clin Nucl Med, 2000, 25(1):65-66.
[38] Mackie GC, Avram AM, Park LS, et al. The saddle sign:bilateral thigh adductor compartment uptake of Tc-99m MDP[J]. Clin Nucl Med, 2004, 29(8):516. DOI:10.1097/01.rlu.0000132955.22968.92.
[39] Kulkarni M, Agrawal A, Zade A, et al. Extraosseous accumulation of bone scan tracer 99Tcm-methylene diphosphonate in a phlebolith[J]. Indian J Nucl Med, 2012, 27(1):42-44. DOI:10.4103/0972-3919.108857.
[40] Silberstein EB, Delong S. Femoral artery calcification. Detection by bone scintigraphy[J]. Clin Nucl Med, 1985, 10(10):738-739.
[41] Thomas BG, Silverman ED. Focal uptake of Tc-99m MDP in a gossypiboma[J]. Clin Nucl Med, 2008, 33(4):290-291. DOI:10.1097/RLU.0b013e3181662b41.
相似文献/References:
[1]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[2]李欢欢,李素平,游金辉.小细胞肺癌伴副肿瘤综合征患者骨显像示肌肉摄取一例[J].国际放射医学核医学杂志,2014,38(2):140.[doi:10.3760/cma.j.issn.1673-4114.2014.02.016]
[3]刘道佳,唐明灯,林端瑜,等.99Tcm-MDP全身骨显像、99Tcm-MDP SPECT-CT和18F-FDG SPECT-CT探测脊柱转移瘤的比较[J].国际放射医学核医学杂志,2011,35(2):89.[doi:10.3760/cma.j.issn.1673-4114.2011.02.006]
LIU Dao-jia,TANG Ming-deng,LIN Duan-yu,et al.Comparision of the value of 99Tcm-MDP bone scintigraphy, 99Tcm-MDP SPECT-CT and 18F-FDG SPECT-CT in detecting bone metastases of spine[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):89.[doi:10.3760/cma.j.issn.1673-4114.2011.02.006]
[4]王渊恺,袁杰,张光明,等.鼻咽癌在全身骨显像鼻部感兴趣区放射性异常的分析[J].国际放射医学核医学杂志,2011,35(1):20.[doi:10.3760/cma.j.issn.1673-4114.2011.01.006]
WANG Yuan-kai,YUAN Jie,ZHANG Guang-ming,et al.Study on nasal radioactive anomalies of nasopharyngeal carcinoma in bone imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):20.[doi:10.3760/cma.j.issn.1673-4114.2011.01.006]
[5]徐海青,段俊,吴边.全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究[J].国际放射医学核医学杂志,2011,35(1):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
XU Hai-qing,DUAN Jun,WU Bian.Study of relationship between the bone imaging, level of PSA and pathology grade in diagnosis of prostate carcinoma bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
[6]苏莉,黄诚刚,牛文强,等.25例血清PTH升高的甲状旁腺相关疾病患者的诊断[J].国际放射医学核医学杂志,2010,34(2):84.[doi:10.3760/cma.j.issn.1673-4114.2010.02.005]
SU Li,HUANG Cheng-gang,NIU Wen-qiang,et al.Nuclear medicine diagnostic experience for 25 patients with parathyroid disease accompanied elevated serum PTH level[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):84.[doi:10.3760/cma.j.issn.1673-4114.2010.02.005]
[7]黄诚刚,陈小艳,马春清,等.血清FPSA/TPSA及性腺激素测定结合核素骨显像在前列腺癌诊断、复发和转移中的临床价值[J].国际放射医学核医学杂志,2010,34(6):337.[doi:10.3760/cma.j.issn.1673-4114,2010.06.005]
HUANG Cheng-gang,CHEN Xiao-yan,MA Chun-qing,et al.Evaluation of serum FPSA/TPSA and hormone determination combinded with nuclide bone imaging in diagnosis of prostate carcinoma and its recidivation and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):337.[doi:10.3760/cma.j.issn.1673-4114,2010.06.005]
[8]陶欣慰,黄钢.18F-FDGPET与99Tcm-MDP骨显像在诊断肿瘤骨转移中的比较[J].国际放射医学核医学杂志,2010,34(6):352.[doi:10.3760/cma.j.issn.1673-4114,2010.06.008]
TAO Xin-wei,HUANG Gang.Comparasion of 18F-FDG PET and 99Tcm-MDP bone imaging in diagnosis of bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):352.[doi:10.3760/cma.j.issn.1673-4114,2010.06.008]
[9]冯菲,赵德善,耿会霞,等.原发性腹膜砂粒体癌99Tcm-亚甲基二膦酸盐SPECT-CT全身骨显像一例报告[J].国际放射医学核医学杂志,2009,33(5):285.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.009]
[10]郭树龙,张久君.相对低剂量甲泼尼龙联合99Tc-MDP治疗老年Graves眼病的疗效观察[J].国际放射医学核医学杂志,2009,33(5):287.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.010]
GUO Shu-long,ZHA NG Jiu-jun.Efficacy of combined 99Tc-methylenediphosphonate and lower-dose meth ylprednisolone in the treatment of old patients with moderate-to-severe Graves ophthalmopathy[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):287.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.010]